Author Affiliations: Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
In 1990, the International AIDS Conference was last held in the United States. The US Food and Drug Administration had approved only 1 antiretroviral drug to treat human immunodeficiency virus (HIV) infection (zidovudine, approved in 1987 [Figure]). Highly active antiretroviral therapy, which has made it possible to reduce the risk of HIV transmission and for infected individuals to live longer and healthier, was still 5 years in the future.1 The AIDS epidemic remained very much out of control in the United States and around the world. Each year brought many more infections and deaths, and the expanding pandemic threatened to overwhelm the capacity for an effective response.
Steinbrook R. HIV/AIDS in 1990 and 2012: From San Francisco to Washington, DC. JAMA. 2012;308(4):345–346. doi:10.1001/jama.2012.7855
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: